Prevention and treatment of CCV in patients undergoing cataract phacoemulsification

The study was hold on the basis of LLC «Eye Microsurgery» in Astrakhan.Purpose: clinical evaluation the influence of Systane Balance (Alcon) the condition of the «ocular surface comfort» at patients with phaco.Materials and methods. 60 patients took part in the study. 30 men and 30 women aged from 6...

Full description

Bibliographic Details
Main Authors: E. Yu. Yazykova, L. Sh. Ramazanova
Format: Article
Language:Russian
Published: Ophthalmology Publishing Group 2016-01-01
Series:Oftalʹmologiâ
Subjects:
Online Access:https://www.ophthalmojournal.com/opht/article/view/278
_version_ 1797875524832329728
author E. Yu. Yazykova
L. Sh. Ramazanova
author_facet E. Yu. Yazykova
L. Sh. Ramazanova
author_sort E. Yu. Yazykova
collection DOAJ
description The study was hold on the basis of LLC «Eye Microsurgery» in Astrakhan.Purpose: clinical evaluation the influence of Systane Balance (Alcon) the condition of the «ocular surface comfort» at patients with phaco.Materials and methods. 60 patients took part in the study. 30 men and 30 women aged from 68 to 80 years. After the first survey the patients were divided into two groups by means of random choice (15 men and 15 women in each group). Three days before the surgery Both groups of patients received antibiotics (Vigamox (Alcon) and NSAIDs (Nevanac, Alcon) according to the standard scheme for preoperative preparation (during 3 days before operation). These drugs were also recommended in the postoperative period. Systane Balance (1 drop 2‑3 times a day) was prescribed for the first group in 2 weeks before phaco. The second group didn’t get any artificial tears. Systane Balance had been chosen as an artificial tears as its composition is very close to the natural tear film, compensates the deficiency of the lipid layer that is broken when meibomean gland dysfunction (MGD) thus it prevents from increasing tear film osmolarity and its rupture.Results: In 60% (36 people) SSG was due to dysfunction of the meibomian glands, and 40% (24 people) had a different genesis (endocrine pathology, receiving β-blockers for local and systemic effects, long-term use of drugs containing the preservative benzalkonium chloride, menopause). One week after phacoemulsification all patients of group 1, treated with the drug Sisteyn Balance dramatically decreased the severity of complaints of dry eye, foreign body sensation, burning, lacrimation, blurred vision in comparison with the group without artificial tears One month after surgery, these complaints were even less pronounced. At the same time, subjective complaints in patients of the second group observed significantly more frequently than before surgery.Conclusions. The patients who belong to the senior age group have MGD much more frequently (up to 60%). We received the optimization of the postoperative course, the improvement the quality of life of such patients and prevention from complications is possible in case of Dry Eye treatment, that is associated with MGD, with the help of Systane Balance.
first_indexed 2024-04-10T01:48:53Z
format Article
id doaj.art-7785307f42c143b38542c810102a18c9
institution Directory Open Access Journal
issn 1816-5095
2500-0845
language Russian
last_indexed 2024-04-10T01:48:53Z
publishDate 2016-01-01
publisher Ophthalmology Publishing Group
record_format Article
series Oftalʹmologiâ
spelling doaj.art-7785307f42c143b38542c810102a18c92023-03-13T09:08:36ZrusOphthalmology Publishing GroupOftalʹmologiâ1816-50952500-08452016-01-01124586210.18008/1816-5095-2015-4-58-62268Prevention and treatment of CCV in patients undergoing cataract phacoemulsificationE. Yu. Yazykova0L. Sh. Ramazanova1ООО Микрохирургия глазаООО Микрохирургия глазаThe study was hold on the basis of LLC «Eye Microsurgery» in Astrakhan.Purpose: clinical evaluation the influence of Systane Balance (Alcon) the condition of the «ocular surface comfort» at patients with phaco.Materials and methods. 60 patients took part in the study. 30 men and 30 women aged from 68 to 80 years. After the first survey the patients were divided into two groups by means of random choice (15 men and 15 women in each group). Three days before the surgery Both groups of patients received antibiotics (Vigamox (Alcon) and NSAIDs (Nevanac, Alcon) according to the standard scheme for preoperative preparation (during 3 days before operation). These drugs were also recommended in the postoperative period. Systane Balance (1 drop 2‑3 times a day) was prescribed for the first group in 2 weeks before phaco. The second group didn’t get any artificial tears. Systane Balance had been chosen as an artificial tears as its composition is very close to the natural tear film, compensates the deficiency of the lipid layer that is broken when meibomean gland dysfunction (MGD) thus it prevents from increasing tear film osmolarity and its rupture.Results: In 60% (36 people) SSG was due to dysfunction of the meibomian glands, and 40% (24 people) had a different genesis (endocrine pathology, receiving β-blockers for local and systemic effects, long-term use of drugs containing the preservative benzalkonium chloride, menopause). One week after phacoemulsification all patients of group 1, treated with the drug Sisteyn Balance dramatically decreased the severity of complaints of dry eye, foreign body sensation, burning, lacrimation, blurred vision in comparison with the group without artificial tears One month after surgery, these complaints were even less pronounced. At the same time, subjective complaints in patients of the second group observed significantly more frequently than before surgery.Conclusions. The patients who belong to the senior age group have MGD much more frequently (up to 60%). We received the optimization of the postoperative course, the improvement the quality of life of such patients and prevention from complications is possible in case of Dry Eye treatment, that is associated with MGD, with the help of Systane Balance.https://www.ophthalmojournal.com/opht/article/view/278факоэмульсификация катарактысиндром сухого глазадисфункция мейбомиевых железслезозаменителисистейн баланс
spellingShingle E. Yu. Yazykova
L. Sh. Ramazanova
Prevention and treatment of CCV in patients undergoing cataract phacoemulsification
Oftalʹmologiâ
факоэмульсификация катаракты
синдром сухого глаза
дисфункция мейбомиевых желез
слезозаменители
систейн баланс
title Prevention and treatment of CCV in patients undergoing cataract phacoemulsification
title_full Prevention and treatment of CCV in patients undergoing cataract phacoemulsification
title_fullStr Prevention and treatment of CCV in patients undergoing cataract phacoemulsification
title_full_unstemmed Prevention and treatment of CCV in patients undergoing cataract phacoemulsification
title_short Prevention and treatment of CCV in patients undergoing cataract phacoemulsification
title_sort prevention and treatment of ccv in patients undergoing cataract phacoemulsification
topic факоэмульсификация катаракты
синдром сухого глаза
дисфункция мейбомиевых желез
слезозаменители
систейн баланс
url https://www.ophthalmojournal.com/opht/article/view/278
work_keys_str_mv AT eyuyazykova preventionandtreatmentofccvinpatientsundergoingcataractphacoemulsification
AT lshramazanova preventionandtreatmentofccvinpatientsundergoingcataractphacoemulsification